Director/PDMR Shareholding

Summary by AI BETAClose X

Victrex plc announced on February 12, 2026, that its Chief Executive Officer, Dr. James Routh, was granted nil-cost options over a total of 318,449 ordinary shares. These awards include buy-out awards totaling 146,448 shares to compensate for forfeited incentives from his previous employer, with vesting dates ranging from December 2025 to November 2027, subject to performance conditions. Additionally, Dr. Routh received a 2026 LTIP award of 172,001 shares, valued at 175% of his base salary, which will vest based on EPS, TSR, ROIC, and sustainability targets over three years, with a five-year post-grant holding period.

Disclaimer*

Companies

Victrex plc (VCT)
UK 100